Search Results 301-310 of 14437 for albumin

  1. Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

    Documented serum albumin <3 g/dL at Screening, and within 72 hours prior to first dose if first dose occurs more than 72 hours post screening (both labs at ...

  2. PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Subjects With Stage IV Untreated Pancreatic Cancer - Mayo Clinic

    Screen labs of Hemoglobin,white blood cells, platelets, absolute neutrophil count (ANC), bilirubin, AST, ALT, serum creatinine, serum albumin, PT/INR, and ...

  3. Oral Epalrestat Therapy in Pediatric Subjects With PMM2-CDG - Mayo Clinic

    Synthetic liver dysfunction (albumin deficiency < 2.8 mmol/L) at screening; or 4. Diagnosis of liver fibrosis (Fibroscan > 7 kPa) confirmed by liver ...

  4. Cyclophosphamide and Vaccine Therapy in Treating Patients with Stage II-III Breast, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Mayo Clinic

    Serum albumin ≥ 3 g/dL; Urinalysis with ≤ 2+ proteinuria; Thyroid-stimulating hormone (TSH) - negative or ≤ normal institutional range; Anti-nuclear ...

  5. Combination of Serabelisib and Insulin Suppressing Diet in Subjects With Advanced Solid Tumors with PIK3CA Mutations - Mayo Clinic

    Albumin level ≥3.0 mg/dL or ≥ the lower limit of normal. 5. Renal: Serum creatinine ≤2 x ULN 13. Ability to take PO medication, be willing to adhere to ...

  6. A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy - Mayo Clinic

    Serum albumin < 2.5 g/dL. History of severe allergic, anaphylactic, or other hypersensitivity reactions to chimeric or humanized antibodies or fusion ...

  7. A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF - Mayo Clinic

    Serum albumin > 3.5 g/dL. Life expectancy of ≥ 12 months. Serum vitamin A level at Screening ≤ ULN of the central laboratory reference range. Women of ...

  8. Cirrhosis Clinical Trials - Mayo Clinic Research

    ... albumin therapy. A Study to Evaluate Voice-enabled Artificial Intelligence to Diagnosis Hepatic Encephalopathy Rochester, MN. early detection of hepatic ...

  9. Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma (HIMALAYA) - Mayo Clinic

    Albumin ≥.8 g/dL. International normalized ratio (INR) ≤1.6. Note: INR prolongation due to anticoagulants for prophylaxis (e.g., atrial fibrillation) in ...

  10. Sorafenib for Hepatopulmonary Syndrome - Mayo Clinic

    Albumin ≥ 2.8 g per deciliter; Total bilirubin ≤ 3 mg per deciliter; Alanine aminotransferase and aspartate aminotransferase ≤ 5 times the upper limit of ...